The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product…

Active Awarded Last action

Contract number
75N93021D00013
Awardee
Awarding agency
Task orders
2 $2,681 obligated

Award facts

Opportunity
Combined order value
$2,681 Current and potential, with all options
Last date to order 87% complete
IDV ceiling <1% used
$107,274,471.00
Maximum order
$107,274,471.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, awarded an indefinite delivery/indefinite quantity (IDIQ) contract to The University of Iowa to provide preclinical development support for HIV, hepatitis B/C, and tuberculosis therapeutic candidates. The IDIQ has a ceiling value of $107,274,471 over a 7-year period of performance from October 2020 to October 2027.

The contract encompasses a range of services across seven task areas, including in vitro testing and screening, synthesis of therapeutic agents, small animal models, formulation development, pharmacology/toxicology studies, and a reagent program to support infectious disease research. Task orders may be issued for activities such as quality assurance planning, compound screening, animal model testing, and manufacturing of clinical dosage forms. The contract does not have a small business set-aside, reflecting the University of Iowa's status as a large public institution. However, the synthesis task area is reserved for small businesses under NAICS code 541715. The University of Iowa has been awarded multiple task orders to date, including for quality control support and to fund the guaranteed minimum contract value.

Description

The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product discovery to those required to support clinical trials and/O

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N93021D00013?

75N93021D00013 was awarded to The University Of Iowa by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on October 15, 2020.

How much is contract 75N93021D00013 worth?

Orders under 75N93021D00013 have obligated $2,681. 75N93021D00013's own ceiling is $107,274,471. A single order can be worth up to $107,274,471.

How many orders have been placed under contract 75N93021D00013?

2 orders have been placed under 75N93021D00013, the latest on April 15, 2021.

Who can order from contract 75N93021D00013?

75N93021D00013 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N93021D00013 part of a contract vehicle?

Yes. 75N93021D00013 is part of Preclinical Services for HIV Therapeutics.

Was contract 75N93021D00013 competed?

The extent of competition for 75N93021D00013 was full and open competition. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV